886 related articles for article (PubMed ID: 26574877)
1. Is benign prostatic obstruction surgery indicated for improving overactive bladder symptoms in men with lower urinary tract symptoms?
Cornu JN; Grise P
Curr Opin Urol; 2016 Jan; 26(1):17-21. PubMed ID: 26574877
[TBL] [Abstract][Full Text] [Related]
2. Analysis of bladder vascular resistance before and after prostatic surgery in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
Wada N; Watanabe M; Kita M; Matsumoto S; Kakizaki H
Neurourol Urodyn; 2012 Jun; 31(5):659-63. PubMed ID: 22488529
[TBL] [Abstract][Full Text] [Related]
3. Long-term safety and efficacy of single-tablet combinations of solifenacin and tamsulosin oral controlled absorption system in men with storage and voiding lower urinary tract symptoms: results from the NEPTUNE Study and NEPTUNE II open-label extension.
Drake MJ; Chapple C; Sokol R; Oelke M; Traudtner K; Klaver M; Drogendijk T; Van Kerrebroeck P;
Eur Urol; 2015 Feb; 67(2):262-70. PubMed ID: 25070148
[TBL] [Abstract][Full Text] [Related]
4. Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods (UPSTREAM) for diagnosis and management of bladder outlet obstruction in men: study protocol for a randomised controlled trial.
Bailey K; Abrams P; Blair PS; Chapple C; Glazener C; Horwood J; Lane JA; McGrath J; Noble S; Pickard R; Taylor G; Young GJ; Drake MJ; Lewis AL
Trials; 2015 Dec; 16():567. PubMed ID: 26651344
[TBL] [Abstract][Full Text] [Related]
5. Prediction of persistent storage symptoms after transurethral resection of the prostate in patients with benign prostatic enlargement.
Choi H; Kim JH; Shim JS; Park JY; Kang SH; Moon du G; Cheon J; Lee JG; Kim JJ; Bae JH
Urol Int; 2014; 93(4):425-30. PubMed ID: 25300422
[TBL] [Abstract][Full Text] [Related]
6. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
[TBL] [Abstract][Full Text] [Related]
7. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
Silva J; Silva CM; Cruz F
Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
[TBL] [Abstract][Full Text] [Related]
8. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
[TBL] [Abstract][Full Text] [Related]
9. Objective impacts of tadalafil on storage and voiding function in male patients with benign prostatic hyperplasia: 1-year outcomes from a prospective urodynamic study.
Matsukawa Y; Takai S; Majima T; Funahashi Y; Sassa N; Kato M; Yamamoto T; Gotoh M
World J Urol; 2019 May; 37(5):867-872. PubMed ID: 30121825
[TBL] [Abstract][Full Text] [Related]
10. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
Jiang YH; Wang CC; Kuo HC
PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
[TBL] [Abstract][Full Text] [Related]
11. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
[TBL] [Abstract][Full Text] [Related]
12. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate.
Rademakers KL; van Koeveringe GA; Oelke M
Curr Opin Urol; 2016 Jan; 26(1):3-10. PubMed ID: 26574876
[TBL] [Abstract][Full Text] [Related]
13. Urodynamic findings in young men with chronic lower urinary tract symptoms.
Karami H; Valipour R; Lotfi B; Mokhtarpour H; Razi A
Neurourol Urodyn; 2011 Nov; 30(8):1580-5. PubMed ID: 21780163
[TBL] [Abstract][Full Text] [Related]
14. Effects of medical therapy or surgery on prostatic and bladder resistive indices in patients with benign prostatic hyperplasia.
Bulut S; Ozden C; Aktas BK; Deren T; Tagci S; Gokkaya CS; Baykam MM; Memis A
Urol Int; 2015; 94(2):181-6. PubMed ID: 25139617
[TBL] [Abstract][Full Text] [Related]
15. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial.
Kaplan SA; He W; Koltun WD; Cummings J; Schneider T; Fakhoury A
Eur Urol; 2013 Jan; 63(1):158-65. PubMed ID: 22831853
[TBL] [Abstract][Full Text] [Related]
16. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis of benign prostatic obstruction: Development of a clinical nomogram.
De Nunzio C; Autorino R; Bachmann A; Briganti A; Carter S; Chun F; Novara G; Sosnowski R; Thiruchelvam N; Tubaro A; Ahyai S;
Neurourol Urodyn; 2016 Feb; 35(2):235-40. PubMed ID: 25524269
[TBL] [Abstract][Full Text] [Related]
18. [Male non-neurogenic overactive bladder].
Phé V; Gamé X
Prog Urol; 2020 Nov; 30(14):880-886. PubMed ID: 33220816
[TBL] [Abstract][Full Text] [Related]
19. Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered?
Chung A; Woo HH
Curr Opin Urol; 2016 Jan; 26(1):42-8. PubMed ID: 26555693
[TBL] [Abstract][Full Text] [Related]
20. Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.
McKeage K
Clin Drug Investig; 2013 Jan; 33(1):71-91. PubMed ID: 23288694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
